Company / SG&A Expense
MeiraGTx Holdings plc SG&A Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$54.2M
FY2025
5-year range
$43.8M / $54.2M
FY2021-FY2025
Trend
+14.6%
vs FY2024
Sector context
#152 of 213
Health Care
What the data says
At $54M, MeiraGTx Holdings plc's sg&a expense ranks #62 of 213 in the Health Care sector. Increased from $47M to $54M over the past 2 years.
Based on SEC 10-K filings.
$54M in FY2025 with a 5-year CAGR of +4.2%.
Increased from $47M to $54M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
#62 of 213 in Health CareTop 29% of 213This company $54.2M Sector average $722.3M
▼
-92.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 14.6% year-over-year.
- Ranks #152 out of 213 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $54.2M | +14.6% |
| FY2024 | $47.3M | +0.0% |
| FY2023 | $47.3M | +1.6% |
| FY2022 | $46.5M | +6.4% |
| FY2021 | $43.8M | -1.0% |
| FY2020 | $44.2M | -5.3% |
| FY2019 | $46.7M | +4.9% |
| FY2018 | $44.5M | +377.0% |
| FY2017 | $9.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026